Diseases of the Colon & Rectum

, Volume 40, Issue 8, pp 973–976 | Cite as

Pneumocystis Carinii pneumonia postrestorative proctocolectomy for ulcerative colitis: A role for perioperative prophylaxis in the cyclosporine era?

Report of a case and review of the literature
  • Aaron M. Scott
  • Gregory A. Myers
  • Bruce A. Harms
Case Reports


PURPOSE: Medical management of severe ulcerative colitis has used cyclosporine with increasing frequency as an adjuvant to systemic steroids and mercaptopurine. However, the effects of combined management with cyclosporine and prednisone may lead to significant immune compromise and adversely affect operative morbidity in the event urgent surgery is required. METHODS: A case is reported of a 43-year-old white male who presented with severe ulcerative colitis. The patient had been initially treated with prednisone and cyclosporine for six weeks before surgical intervention. The intractability of his ulcerative colitis caused the patient to present to surgery, where he underwent restorative proctocolectomy. RESULTS: On initial presentation, the patient manifested systemic signs of severe ulcerative colitis with hypoalbuminemia, anemia, and weight loss, despite continuous prednisone and cyclosporine management. Before surgical intervention, a chest x-ray and the patient's respiratory status were normal. A total abdominal colectomy with ileal pouch reconstruction and temporary loop ileostomy were performed without incident. On the fifth postoperative day, the patient developed respiratory failure, which was subsequently diagnosed asPneumocystis carinii pneumonia. Although ventilator support and both aggressive medical and surgical management eventually resulted in successful outcome, significant perioperative morbidity occurred. CONCLUSIONS: In the era of aggressive medical management for ulcerative colitis with both steroids and cyclosporine, the complications of immunosuppression may be significant, including opportunistic pneumonia. Prophylaxis againstP. carinii pneumonia with sulfa antibiotics should be considered, especially in patients for whom proctocolectomy is a potential end point.

Key words

Ulcerative colitis Proctocolectomy Cyclosporine Immunosuppression Pneumocystispneumonia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Santos J, Baudet S, Casellas F, Guarner L, Vilaseca J, Malagelada J. Efficacy of intravenous cyclosporin for steroid refractory attacks of ulcerative colitis. J Clin Gastroenterol 1995;20:285–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Hirschfeld S, Clearfield H. Pharmacologic therapy for inflammatory bowel disease. Am Fam Physician 1995;51:1971–5.PubMedGoogle Scholar
  3. 3.
    Treem WR, Cohen J, Davis PM, Justinich CJ, Hyams JS. Cyclosporin for the treatment of fulminate ulcerative colitis in children: immediate response, long-term results, and impact on surgery. Dis Colon Rectum 1995;38:474–9.PubMedGoogle Scholar
  4. 4.
    Ognibene F, Shelhamer J, Hoffman G,et al. Pneumocyctis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Resp Crit Care Med 1995;151:795–9.PubMedGoogle Scholar
  5. 5.
    Lichtiger S, Present D, Kornbluth A,et al. Cyclosporin in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Dawson T, Ryan P, Findeisen J, Scheinkestel C. Pneumocystis carinii pneumonia following cyclosporin A and methotrexate treated rheumatoid arthritis. J Rheumatol 1992;19:997.PubMedGoogle Scholar
  7. 7.
    McGonigle R, Beaman M, Stone J, Young J, Michael J, Adu D. Does cyclosporin A adversely affect Pneumocystis carinii infection? Postgrad Med J 1988;64:659–62.PubMedCrossRefGoogle Scholar
  8. 8.
    Franson T, Kauffman H, Adams M, Lemann J, Cabrera E, Hanacik L. Cyclosporin therapy and refractory Pneumocystis carinii pneumonia: a potential association. Arch Surg 1987;122:1034–5.PubMedGoogle Scholar
  9. 9.
    Hardy A, Wajszczuk C, Suffredini A, Hakala T, Ho M. Pneumocystis carinii pneumonia in renal transplant recipients treated with cyclosporin and steroids. J Infect Dis 1984;149:143–7.PubMedGoogle Scholar
  10. 10.
    Sistek C, Wordell C, Hauptman S. Adjuvant corticosteroid therapy for Pneumocystis carinii Pneumonia in AIDS patients. Ann Pharmacother 1992;26:1127–33.PubMedGoogle Scholar
  11. 11.
    Olin BR, Hebel SK, Hagemann RC. Pharmacy facts and comparisons. Saint Louis: JB Lippincott, 1995:122.Google Scholar
  12. 12.
    Bernstein C, Kolodny M, Block E, Shanahan F. Pneumocystis carinii pneumonia in patients with ulcerative colitis treated with corticosteroids. Am J Gastroenterol 1993;88:574–7.PubMedGoogle Scholar
  13. 13.
    Sepkowitz K. Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 1993;17(Suppl 2):416–22.Google Scholar
  14. 14.
    Schneider M, Nielsen T, Nelsing S,et al. Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus. J Infect Dis 1995;171:1632–6.PubMedGoogle Scholar
  15. 15.
    Olsen S, Renlund D, O'Connell J,et al. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim-sulfamethoxazole. Transplantation 1993;56:359–62.PubMedGoogle Scholar
  16. 16.
    Fleshner PR, Michelassi F, Rubin M, Hanauer SB, Plevy SE, Targan SR. Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin. Dis Colon Rectum 1995;38:1241–5.PubMedGoogle Scholar
  17. 17.
    Bye M, Cairns-Bazarian A, Ewig J. Markedly reduced mortality associated with corticosteroid therapy of Pneumocystis carinii pneumonia in children with acquired immunodeficiency syndrome. Arch Pediatr Adolesc Med 1994;148:638–41.PubMedGoogle Scholar
  18. 18.
    Sattler F, Feinberg J. New developments in the treatment of Pneumocystis carinii pneumonia. Chest 1992;101:451–7.PubMedGoogle Scholar
  19. 19.
    LaRocco A, Amundson D, Wallace M, Malone J, Oldfield E. Corticosteroids for Pneumocystis carinii pneumonia with acute respiratory failure: experience with rescue therapy. Chest 1992;102:892–5.PubMedGoogle Scholar
  20. 20.
    Bagheri K, Truitt T, Safirstein B. Spontaneous pneumothorax in AIDS patients not receiving prophylaxis against Pneumocystis carinii pneumonia. Chest 1992;101:1473–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Tunon-de-Lara J, Constans J, Vincent M,et al. Spontaneous pneumothorax associated with Pneumocystis carinii pneumonia: successful treatment with talc pleurodesis. Chest 1992;101:1177–8.PubMedGoogle Scholar
  22. 22.
    McClellan M, Miller S, Parsons P, Cohn D. Pneumothorax with Pneumocystis carinii pneumonia in AIDS: incidence and clinical characteristics. Chest 1991;100:1224–8.PubMedGoogle Scholar
  23. 23.
    Puskas J, Mathisen D, Grillo H, Wain J, Wright C, Moncure A. Treatment strategies for bronchopleural fistula. J Thorac Cardiovasc Surg 1995;109:989–95.PubMedGoogle Scholar
  24. 24.
    Smith M, Hanauer S. Pneumocystis carinii pneumonia during cyclosporin therapy for ulcerative colitis. N Engl J Med 1992;327:497–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Sandborn W, Tremaine W. Cyclosporin treatment of inflammatory bowel disease. Mayo Clin Proc 1992;67:981–90.PubMedGoogle Scholar

Copyright information

© American Society of Colon and Rectal Surgeons 1997

Authors and Affiliations

  • Aaron M. Scott
    • 1
  • Gregory A. Myers
    • 1
  • Bruce A. Harms
    • 1
  1. 1.Department of SurgeryUniversity of Wisconsin Hospital and ClinicsMadison

Personalised recommendations